Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue
Patient service revenue, net	$ 539,625	$ 480,723	$ 1,751,584	$ 1,473,639
Operating Expenses
Salaries and benefits	603,510	506,206	1,782,509	1,469,211
General and administrative	896,754	480,614	2,024,165	1,369,018
Depreciation and amortization	5,744	6,056	17,802	17,623
Total Operating Expenses	1,506,008	992,876	3,824,476	2,855,852
Loss from operations	(966,383)	(512,153)	(2,072,892)	(1,382,213)
Other Income (Expenses)
Loss on extinguishment of debt	(66,469)	(290,581)	(374,828)	(290,581)
Change in fair value of debt	(22,101)		(105,499)
Financing cost	(623,216)	(32,324)	(1,063,721)	(32,324)
Amortization of original issue and debt discounts on notes payable and convertible notes	(234,584)	(63,552)	(633,982)	(194,120)
Change in fair value of derivative financial instrument	(238,330)	5,412	(200,165)	5,412
Interest expense	(58,655)	(27,124)	(150,008)	(64,921)
Total other expenses	(1,243,355)	(408,169)	(2,528,203)	(576,534)
Net loss before provision for income taxes	(2,209,738)	(920,322)	(4,601,095)	(1,958,747)
Provision for income taxes
Net loss	$ (2,209,738)	$ (920,322)	$ (4,601,095)	$ (1,958,747)
Net loss per share, basic and diluted:
Basic	$ (0.03)	$ (0.01)	$ (0.06)	$ (0.03)
Fully diluted	$ (0.03)	$ (0.01)	$ (0.06)	$ (0.03)
Weighted average number of common shares:
Basic	79,323,131	69,625,763	76,757,809	68,805,330
Fully diluted	79,323,131	69,625,763	76,757,809	68,805,330